Eleven Therapeutics

About:

Eleven Therapeutics is a research firm that uses the power of RNAi technology to help create therapeutics.

Website: https://www.eleventx.com/

Twitter/X: eleventx

Top Investors: Innovate UK, Bill & Melinda Gates Foundation, Kindred Capital, Entrée Capital, NFX Bio

Description:

Eleven Therapeutics is a biotechnology company at the forefront of the artificial intelligence revolution in medicinal nucleic acids. The new generation of RNAi therapies is introduced by merging artificial intelligence, parallel functional testing, and combinatorial chemistry. SCSI-RNA is a programmable molecule that can be used to target any disease or biological target of interest.

Total Funding Amount:

$26.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tel Aviv, Tel Aviv, Israel

Founded Date:

2020-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-08-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai